Plain-English translation of NCT06907420 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a non-drug approach called 40 Hz visual stimulation — rapid flashing lights shown to your eyes — to help reduce negative symptoms of schizophrenia, such as low motivation, emotional flatness, or difficulty speaking. Researchers believe this specific pattern of light stimulation may help brain activity and improve how you feel and function. Half the participants will receive the light sessions plus their regular treatment, while the other half will continue with treatment as usual.
Negative symptoms of schizophrenia — like lack of motivation, social withdrawal, and emotional numbness — are often difficult to treat with current medications. This trial explores whether this new treatment might offer relief when added to your existing care.
You likely qualify if…
You likely don't qualify if…
If you're in the treatment group, you'll visit the lab for one week (Monday through Friday), with each session lasting about one hour. During each session, you'll lie down in a comfortable position, close your eyes, and be exposed to rapidly flashing lights while relaxed or resting — researchers encourage you to fall asleep if you can. On the first day, brain activity will be recorded using EEG (painless sensors on your scalp). You'll also complete brief mood and thinking questionnaires before and after the week. Throughout, you'll continue your regular medications and therapy as usual.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Germany